---
document_datetime: 2023-09-21 20:25:14
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rukobia-epar-all-authorised-presentations_en.pdf
document_name: rukobia-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7148868
conversion_datetime: 2025-12-28 17:29:40.769211
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging   | Pack size            |
|------------------|-------------------|------------|--------------------------|---------------------------|-----------------------|----------------------|
| EU/1/20/1518/001 | Rukobia           | 600 mg     | Prolonged-release tablet | Oral use                  | bottle (HDPE)         | 60 tablets           |
| EU/1/20/1518/002 | Rukobia           | 600 mg     | Prolonged-release tablet | Oral use                  | bottle (HDPE)         | 180 (3 x 60) tablets |